American Equity Reports Strong Earnings Driven by Continued Execution of AEL 2.0 Strategy with Private Asset Allocation Growing to 18.4%
American Equity Life (AEL) reported strong Q3 2022 results with a net income of $301.7 million, or $3.41 per share, a significant increase from $141.9 million in Q3 2021. Non-GAAP operating income was $87.4 million, or $0.99 per diluted share. The company ranked #1 in customer satisfaction per J.D. Power's 2022 study. AEL repurchased $154 million worth of shares in Q3, totaling $522 million for the year. Investment strategies showed promising results with a 2.73% investment spread. However, sales of fixed index annuities (FIAs) fell 6% from the previous quarter.
- Net income rose to $301.7 million in Q3 2022, up from $141.9 million in Q3 2021.
- Non-GAAP operating income increased to $87.4 million, or $0.99 per share.
- Ranked #1 for Customer Satisfaction among Annuity Providers by J.D. Power.
- Repurchased $154 million of common shares in Q3 2022, totaling $522 million year-to-date.
- Investment spread improved to 2.73%, up from 2.40% in Q3 2021.
- Sales of fixed index annuities decreased by 6% compared to the previous quarter.
- Non-GAAP operating income excluding notable items fell from $136.3 million in Q3 2021 to $87.4 million in Q3 2022.
Company Highlights
-
Q3 2022 net income available to common stockholders of
, or$301.7 million per diluted common share compared to$3.41 , or$141.9 million per diluted common share for Q3 2021$1.53
-
Non-GAAP operating income1 available to common stockholders excluding notable items for the third quarter 2022 was
, or$87.4 million per diluted common share$0.99
-
Only notable item this quarter, the annual actuarial update, positively impacted non-GAAP operating income1 by
, or$26.6 million per common diluted share$0.30
-
American Equity Life ranked #1 annuity provider for Customer Satisfaction among Annuity Providers2 in theJ.D. Power 2022 U.S. Individual Annuity Study
-
Repurchased
or 4.2 million common shares in Q3 2022 bringing total year-to-date to$154 million or 13.6 million shares$522 million
-
Private asset deployment momentum continues with approximately
sourced in the quarter$1.3 billion
-
Approximately
increase in notional value3 of reinsurance ceded to North End Re., a subsidiary of Brookfield Reinsurance, that earns recurring "fee-like" revenues for 6-7 years, growing total balance to$500 million $4.9 billion
American Equity's President and CEO,
Non-GAAP operating income1 available to common stockholders for the third quarter of 2022 was
The one notable item in each quarter, actuarial assumption revisions utilized in the determination of deferred policy acquisition costs, deferred sales inducements, and the liability for future policy benefits to be paid for lifetime income benefit riders (LIBR), positively impacted non-GAAP operating income by
The year-over-year change in quarterly non-GAAP operating income1 available to common stockholders excluding the impact of actuarial assumption revisions reflected reduced equity index credits due to the decline in equity markets and increases in amortization of the deferred acquisition cost and deferred sales inducement assets offset partly by a substantial increase in average yield on invested assets.
For the third quarter of 2022, net investment income increased
Compared to the third quarter of 2021, the change in the liability for future benefits to be paid for LIBR decreased by
Compared to the third quarter of 2021, the change in amortization of deferred policy acquisition and sales inducement costs increased by
As of
STRONG INVESTMENT MANAGEMENT RESULTS
American Equity’s investment spread was
Average yield on invested assets was
During the quarter, investment asset purchases totaled
The aggregate cost of money for annuity liabilities of
SALES FOCUS ON FIA AND PRICING DISCIPLINE5
Third quarter sales were
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
The forward-looking statements in this release or that American Equity uses on its conference call, such as ability, aim, anticipate, assume, become, believe, can, commit, continue, could, estimate, expect, exposure, forward, future, goal, grow, guidance, intend, likely, look to, may, might, model, opportunity, outlook, over time, plan, potential, prepare, project, ramp, risk, scenario, should, signal, strategy, stress test, target, to be, toward, trends, will, would, and their derivative forms and similar words, as well as any projections of future results, are based on assumptions and expectations that involve risks and uncertainties, including the "Risk Factors" the company describes in its
CONFERENCE CALL
American Equity will hold a conference call to discuss third quarter 2022 earnings on
The conference call will be webcast live on the Internet. Investors and interested parties who wish to listen to the webcast may register to access it on our IR website at https://ir.american-equity.com. An audio replay will also be available via the same link on our website shortly after the completion of the call for 30 days.
The call may also be accessed by telephone. Investors and interested parties may register for the call with the form available at this link, and upon submission (and via follow-up email) will receive the dial-in number and a unique PIN to access the call. Registration is available now or any time up to and during the time of the call. Registration is also available by visiting our IR website at https://ir.american-equity.com.
ABOUT AMERICAN EQUITY
At
1 |
Use of non-GAAP financial measures, including those that isolate notable items, is discussed in this release in the tables that follow the text of the release. |
|
2 |
American Equity received the highest score in the |
|
3 |
Notional value represents the initial cash surrender value of business ceded subject to recurring fees under reinsurance agreements. |
|
4 |
Non-trendable items are the impact of investment yield – additional prepayment income and cost of money effect of over (under) hedging as shown in our |
|
5 |
For the purposes of this document, all references to sales are on a gross basis. Gross sales is defined as sales before the use of reinsurance. |
Unaudited (Dollars in thousands, except per share data) |
|||||||||||||||
Consolidated Statements of Operations |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Revenues: |
|
|
|
|
|
|
|
||||||||
Premiums and other considerations |
$ |
2,839 |
|
|
$ |
15,841 |
|
|
$ |
16,748 |
|
|
$ |
43,649 |
|
Annuity product charges |
|
60,819 |
|
|
|
58,480 |
|
|
|
168,688 |
|
|
|
182,321 |
|
Net investment income |
|
609,737 |
|
|
|
526,366 |
|
|
|
1,769,468 |
|
|
|
1,522,876 |
|
Change in fair value of derivatives |
|
(176,671 |
) |
|
|
(70,701 |
) |
|
|
(1,160,371 |
) |
|
|
826,484 |
|
Net realized gains (losses) on investments |
|
(15,860 |
) |
|
|
4,933 |
|
|
|
(62,259 |
) |
|
|
(2,764 |
) |
Other revenue |
|
10,989 |
|
|
|
7,644 |
|
|
|
28,773 |
|
|
|
7,644 |
|
Total revenues |
|
491,853 |
|
|
|
542,563 |
|
|
|
761,047 |
|
|
|
2,580,210 |
|
|
|
|
|
|
|
|
|
||||||||
Benefits and expenses: |
|
|
|
|
|
|
|
||||||||
Insurance policy benefits and change in future policy benefits |
|
5,707 |
|
|
|
18,756 |
|
|
|
25,436 |
|
|
|
51,008 |
|
Interest sensitive and index product benefits |
|
121,890 |
|
|
|
817,014 |
|
|
|
729,407 |
|
|
|
2,106,590 |
|
Amortization of deferred sales inducements |
|
127,784 |
|
|
|
(17,172 |
) |
|
|
361,775 |
|
|
|
93,283 |
|
Change in fair value of embedded derivatives |
|
(415,374 |
) |
|
|
(536,404 |
) |
|
|
(2,695,007 |
) |
|
|
(545,104 |
) |
Interest expense on notes payable |
|
8,984 |
|
|
|
6,535 |
|
|
|
21,870 |
|
|
|
19,322 |
|
Interest expense on subordinated debentures |
|
1,333 |
|
|
|
1,342 |
|
|
|
3,996 |
|
|
|
3,994 |
|
Amortization of deferred policy acquisition costs |
|
183,182 |
|
|
|
(1,588 |
) |
|
|
550,962 |
|
|
|
185,329 |
|
Other operating costs and expenses |
|
59,532 |
|
|
|
56,518 |
|
|
|
177,575 |
|
|
|
177,433 |
|
Total benefits and expenses |
|
93,038 |
|
|
|
345,001 |
|
|
|
(823,986 |
) |
|
|
2,091,855 |
|
Income before income taxes |
|
398,815 |
|
|
|
197,562 |
|
|
|
1,585,033 |
|
|
|
488,355 |
|
Income tax expense |
|
86,214 |
|
|
|
44,697 |
|
|
|
345,633 |
|
|
|
107,500 |
|
Net income |
|
312,601 |
|
|
|
152,865 |
|
|
|
1,239,400 |
|
|
|
380,855 |
|
Less: Net income (loss) available to noncontrolling interests |
|
1 |
|
|
|
— |
|
|
|
(3 |
) |
|
|
— |
|
Net income available to |
|
312,600 |
|
|
|
152,865 |
|
|
|
1,239,403 |
|
|
|
380,855 |
|
Less: Preferred stock dividends |
|
10,918 |
|
|
|
10,918 |
|
|
|
32,756 |
|
|
|
32,756 |
|
Net income available to |
$ |
301,682 |
|
|
$ |
141,947 |
|
|
$ |
1,206,647 |
|
|
$ |
348,099 |
|
|
|
|
|
|
|
|
|
||||||||
Earnings per common share |
$ |
3.44 |
|
|
$ |
1.53 |
|
|
$ |
13.07 |
|
|
$ |
3.69 |
|
Earnings per common share - assuming dilution |
$ |
3.41 |
|
|
$ |
1.53 |
|
|
$ |
12.94 |
|
|
$ |
3.67 |
|
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding (in thousands): |
|
|
|
|
|
|
|
||||||||
Earnings per common share |
|
87,707 |
|
|
|
92,478 |
|
|
|
92,339 |
|
|
|
94,326 |
|
Earnings per common share - assuming dilution |
|
88,581 |
|
|
|
93,044 |
|
|
|
93,270 |
|
|
|
94,867 |
|
NON-GAAP FINANCIAL MEASURES |
|||||||||||||||
In addition to net income available to common stockholders, we have consistently utilized non-GAAP operating income available to common stockholders and non-GAAP operating income available to common stockholders per common share - assuming dilution, non-GAAP financial measures commonly used in the life insurance industry, as economic measures to evaluate our financial performance. Non-GAAP operating income available to common stockholders equals net income available to common stockholders adjusted to eliminate the impact of items that fluctuate from quarter to quarter in a manner unrelated to core operations, and we believe measures excluding their impact are useful in analyzing operating trends. The most significant adjustments to arrive at non-GAAP operating income available to common stockholders eliminate the impact of fair value accounting for our fixed index annuity business. These adjustments are not economic in nature but rather impact the timing of reported results. We believe the combined presentation and evaluation of non-GAAP operating income available to common stockholders together with net income available to common stockholders provides information that may enhance an investor’s understanding of our underlying results and profitability. |
|||||||||||||||
Reconciliation from Net Income Available to Common Stockholders to Non-GAAP Operating Income Available to Common Stockholders and Non-GAAP Operating Income Available to Common Stockholders, Excluding Notable Items |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Net income available to |
$ |
301,682 |
|
|
$ |
141,947 |
|
|
$ |
1,206,647 |
|
|
$ |
348,099 |
|
Adjustments to arrive at non-GAAP operating income available to common stockholders: (a) |
|
|
|
|
|
|
|
||||||||
Net realized (gains) losses on financial assets, including credit losses |
|
9,738 |
|
|
|
(3,900 |
) |
|
|
51,595 |
|
|
|
2,528 |
|
Change in fair value of derivatives and embedded derivatives |
|
(248,823 |
) |
|
|
(75,879 |
) |
|
|
(1,219,322 |
) |
|
|
(172,746 |
) |
Income taxes |
|
51,403 |
|
|
|
17,285 |
|
|
|
256,120 |
|
|
|
36,801 |
|
Non-GAAP operating income available to common stockholders |
|
114,000 |
|
|
|
79,453 |
|
|
|
295,040 |
|
|
|
214,682 |
|
Impact of excluding notable items (b) |
|
(26,572 |
) |
|
|
56,801 |
|
|
|
(26,572 |
) |
|
|
56,801 |
|
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
87,428 |
|
|
$ |
136,254 |
|
|
$ |
268,468 |
|
|
$ |
271,483 |
|
|
|
|
|
|
|
|
|
||||||||
Per common share - assuming dilution: |
|
|
|
|
|
|
|
||||||||
Net income available to |
$ |
3.41 |
|
|
$ |
1.53 |
|
|
$ |
12.94 |
|
|
$ |
3.67 |
|
Adjustments to arrive at non-GAAP operating income available to common stockholders: |
|
|
|
|
|
|
|
||||||||
Net realized (gains) losses on financial assets, including credit losses |
|
0.11 |
|
|
|
(0.04 |
) |
|
|
0.55 |
|
|
|
0.02 |
|
Change in fair value of derivatives and embedded derivatives |
|
(2.81 |
) |
|
|
(0.82 |
) |
|
|
(13.07 |
) |
|
|
(1.82 |
) |
Income taxes |
|
0.58 |
|
|
|
0.18 |
|
|
|
2.75 |
|
|
|
0.39 |
|
Non-GAAP operating income available to common stockholders |
|
1.29 |
|
|
|
0.85 |
|
|
|
3.17 |
|
|
|
2.26 |
|
Impact of excluding notable items |
|
(0.30 |
) |
|
|
0.61 |
|
|
|
(0.29 |
) |
|
|
0.60 |
|
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
0.99 |
|
|
$ |
1.46 |
|
|
$ |
2.88 |
|
|
$ |
2.86 |
|
Notable Items |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Notable items impacting non-GAAP operating income available to common stockholders: |
|
|
|
|
|
|
|
||||||||
Impact of actuarial assumption updates |
$ |
26,572 |
|
$ |
(56,801 |
) |
|
$ |
26,572 |
|
$ |
(56,801 |
) |
||
Total notable items (b) |
$ |
26,572 |
|
|
$ |
(56,801 |
) |
|
$ |
26,572 |
|
|
$ |
(56,801 |
) |
(a) |
Adjustments to net income available to common stockholders to arrive at non-GAAP operating income available to common stockholders are presented net of related adjustments to amortization of deferred sales inducements (DSI) and deferred policy acquisition costs (DAC) and accretion of lifetime income benefit rider (LIBR) reserves where applicable. |
|
(b) |
Notable items reflect the after-tax impact to non-GAAP operating income available to common stockholders for certain items that do not reflect the company's expected ongoing operations. Notable items primarily include the impact from actuarial assumption updates. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. |
Book Value per Common Share |
|||
|
Q3 2022 |
||
Total stockholders’ equity attributable to |
$ |
3,207,698 |
|
Equity available to preferred stockholders (a) |
|
(700,000 |
) |
Total common stockholders' equity (b) |
|
2,507,698 |
|
Accumulated other comprehensive (income) loss (AOCI) |
|
2,214,388 |
|
Total common stockholders’ equity excluding AOCI (b) |
|
4,722,086 |
|
Net impact of fair value accounting for derivatives and embedded derivatives |
|
(1,217,754 |
) |
Total common stockholders’ equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives (b) |
$ |
3,504,332 |
|
|
|
||
Common shares outstanding |
|
85,966,505 |
|
|
|
||
Book Value per Common Share: (c) |
|
||
Book value per common share |
$ |
29.17 |
|
Book value per common share excluding AOCI (b) |
$ |
54.93 |
|
Book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives (b) |
$ |
40.76 |
|
(a) |
Equity available to preferred stockholders is equal to the redemption value of outstanding preferred stock plus share dividends declared but not yet issued. |
|
(b) |
Total common stockholders' equity, total common stockholders' equity excluding AOCI and total common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives, non-GAAP financial measures, exclude equity available to preferred stockholders. Total common stockholders’ equity and book value per common share excluding AOCI, non-GAAP financial measures, are based on common stockholders’ equity excluding the effect of AOCI. Since AOCI fluctuates from quarter to quarter due to unrealized changes in the fair value of available for sale securities, we believe these non-GAAP financial measures provide useful supplemental information. Total common stockholders' equity and book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives, non-GAAP financial measures, are based on common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives. Since the net impact of fair value accounting for our derivatives and embedded derivatives fluctuates from quarter to quarter and the most significant impacts relate to fair value accounting for our fixed index annuity business and are not economic in nature but rather impact the timing of reported results, we believe these non-GAAP financial measures provide useful supplemental information. |
|
(c) |
Book value per common share including and excluding AOCI and book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives are calculated as total common stockholders’ equity, total common stockholders’ equity excluding AOCI and total common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives divided by the total number of shares of common stock outstanding. |
NON-GAAP FINANCIAL MEASURES |
|||
Average Common Stockholders' Equity and Return on Average Common Stockholders' Equity |
|||
Return on average common stockholders' equity measures how efficiently we generate profits from the resources provided by our net assets. Return on average common stockholders' equity is calculated by dividing net income available to common stockholders, for the trailing twelve months, by average equity available to common stockholders. Non-GAAP operating return on average common stockholders' equity excluding average accumulated other comprehensive income (AOCI) and average net impact of fair value accounting for derivatives and embedded derivatives is calculated by dividing non-GAAP operating income available to common stockholders, for the trailing twelve months, by average common stockholders' equity excluding average AOCI and average net impact of fair value accounting for derivatives and embedded derivatives. We exclude AOCI because AOCI fluctuates from quarter to quarter due to unrealized changes in the fair value of available for sale investments. We exclude the net impact of fair value accounting for derivatives and embedded derivatives as the amounts are not economic in nature but rather impact the timing of reported results. |
|||
|
Twelve Months Ended |
||
|
|
||
Average Common Stockholders' Equity Attributable to |
|
||
Average total stockholders’ equity |
$ |
4,791,453 |
|
Average equity available to preferred stockholders |
|
(700,000 |
) |
Average equity available to common stockholders |
|
4,091,453 |
|
Average AOCI |
|
128,707 |
|
Average common stockholders' equity excluding average AOCI |
|
4,220,160 |
|
Average net impact of fair value accounting for derivatives and embedded derivatives |
|
(741,386 |
) |
Average common stockholders' equity excluding average AOCI and average net impact of fair value accounting for derivatives and embedded derivatives |
|
3,478,774 |
|
Impact of excluding notable items on average common stockholders' equity excluding average AOCI and average net impact of fair value accounting for derivatives and embedded derivatives |
|
(2,669 |
) |
Average common stockholders' equity excluding average AOCI, average net impact of fair value accounting for derivatives and embedded derivatives and notables |
$ |
3,476,105 |
|
|
|
||
Net income available to |
$ |
1,288,865 |
|
Adjustments to arrive at non-GAAP operating income available to common stockholders: (a) |
|
||
Net realized losses on financial assets, including credit losses |
|
59,366 |
|
Change in fair value of derivatives and embedded derivatives |
|
(1,233,866 |
) |
Income taxes |
|
256,503 |
|
Non-GAAP operating income available to common stockholders |
|
370,868 |
|
Impact of excluding notable items (b) |
|
(5,337 |
) |
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
365,531 |
|
|
|
||
Return on Average Common Stockholders' Equity Attributable to |
|
||
Net income available to common stockholders |
|
31.5 |
% |
|
|
||
Return on Average Common Stockholders' Equity Attributable to |
|
||
Non-GAAP operating income available to common stockholders |
|
10.7 |
% |
Non-GAAP operating income available to common stockholders, excluding notable items |
|
10.5 |
% |
Notable Items |
|||
|
Twelve Months Ended |
||
|
|
||
Notable items impacting non-GAAP operating income available to common stockholders: |
|
||
Impact of actuarial assumption updates |
$ |
5,337 |
|
Total notable items (b) |
$ |
5,337 |
|
(a) |
Adjustments to net income available to common stockholders to arrive at non-GAAP operating income available to common stockholders are presented net of related adjustments to amortization of deferred sales inducements (DSI) and deferred policy acquisition costs (DAC) and accretion of lifetime income benefit rider (LIBR) reserves where applicable. |
|
(b) |
Notable items reflect the after-tax impact to non-GAAP operating income available to common stockholders for certain items that do not reflect the company's expected ongoing operations. Notable items primarily include the impact from actuarial assumption updates. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221107006055/en/
(515) 273-3763, sschwartz@american-equity.com
Source:
FAQ
What was American Equity Life's net income for Q3 2022?
How did AEL perform in customer satisfaction according to J.D. Power?
What is the current investment spread for American Equity Life?
How many shares did AEL repurchase in Q3 2022?